Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |